The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
2-acetyltributylcitrate results in increased expression of ACACA mRNA; 2-acetyltributylcitrate results in increased expression of ACACA protein [2-acetyltributylcitrate co-treated with Tetradecanoylphorbol Acetate] results in increased expression of ACACA mRNA
2-acetyltributylcitrate results in increased expression of CD36 mRNA; 2-acetyltributylcitrate results in increased expression of CD36 protein [2-acetyltributylcitrate co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CD36 mRNA
2-acetyltributylcitrate promotes the reaction [Calcitriol results in increased expression of CYP3A4 mRNA]; 2-acetyltributylcitrate promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA]; Calcitriol promotes the reaction [2-acetyltributylcitrate results in increased activity of CYP3A4 protein]; Calcitriol promotes the reaction [2-acetyltributylcitrate results in increased expression of CYP3A4 mRNA]; NR1I2 protein affects the reaction [2-acetyltributylcitrate results in increased expression of CYP3A4 mRNA]
[2-acetyltributylcitrate co-treated with Tetradecanoylphorbol Acetate] results in increased expression of FABP4 mRNA 2-acetyltributylcitrate results in increased expression of FABP4 mRNA
2-acetyltributylcitrate results in increased activity of NR1I2 protein 2-acetyltributylcitrate promotes the reaction [NCOA1 protein binds to NR1I2 protein]; 2-acetyltributylcitrate promotes the reaction [NCOA2 protein binds to NR1I2 protein]; 2-acetyltributylcitrate promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA]; NR1I2 protein affects the reaction [2-acetyltributylcitrate results in increased expression of CYP3A4 mRNA]
[2-acetyltributylcitrate co-treated with Tetradecanoylphorbol Acetate] results in increased expression of SCD1 mRNA 2-acetyltributylcitrate results in increased expression of SCD1 mRNA; 2-acetyltributylcitrate results in increased expression of SCD1 protein
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [AGT protein modified form results in increased abundance of Superoxides]
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid results in increased expression of ATF6 protein 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [fisetin results in increased expression of ATF6 protein]
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [fisetin results in increased expression of ATF6B protein] 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid results in increased expression of ATF6B protein
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid affects the reaction [Methacholine Chloride affects the reaction [CACNA1E protein results in increased transport of Barium]]
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [fisetin results in increased expression of CAPN2 protein] 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid results in increased expression of CAPN2 protein
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased cleavage of CASP1 protein]
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [fisetin results in increased expression of CASP12 protein] 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid results in increased expression of CASP12 protein
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [fisetin results in increased activity of CASP3 protein]; 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Pilocarpine results in increased activity of CASP3 protein] 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Cadmium results in increased cleavage of CASP3 protein]; 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [GW 7845 results in increased activity of CASP3 protein]; [1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid co-treated with Egtazic Acid] inhibits the reaction [Cadmium results in increased cleavage of CASP3 protein]
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid results in increased expression of CASP4 protein 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [fisetin results in increased expression of CASP4 protein]
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Cadmium results in increased cleavage of CASP8 protein]; [1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid co-treated with Egtazic Acid] inhibits the reaction [Cadmium results in increased cleavage of CASP8 protein]
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [2-tert-butylhydroquinone promotes the reaction [CREBBP protein binds to NFE2L2 protein]]
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid results in increased expression of DDIT3 protein 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [fisetin results in increased expression of DDIT3 protein] 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Cadmium results in increased expression of DDIT3 protein]; [Egtazic Acid co-treated with 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid] inhibits the reaction [Cadmium results in increased expression of DDIT3 protein]
[fisetin co-treated with 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid] results in decreased expression of EIF2AK3 protein 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid results in increased expression of EIF2AK3 protein
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Ionomycin results in increased expression of FOS mRNA]; 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [PDGFB protein results in increased expression of FOS mRNA]; 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of FOS mRNA]
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [2-tert-butylhydroquinone promotes the reaction [NFE2L2 protein binds to HMOX1 promoter]]; 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [2-tert-butylhydroquinone results in increased expression of HMOX1 mRNA]
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of and results in increased secretion of IL1B protein]
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Toluene 2,4-Diisocyanate results in increased secretion of IL4 protein]
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of MAPK3 mRNA]
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid affects the localization of NFE2L2 protein 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [2-tert-butylhydroquinone promotes the reaction [CREBBP protein binds to NFE2L2 protein]]; 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [2-tert-butylhydroquinone promotes the reaction [NFE2L2 protein binds to HMOX1 promoter]]; 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [2-tert-butylhydroquinone results in increased activity of NFE2L2 protein]
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of NLRP3 protein]
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Humic Substances results in increased expression of and results in increased phosphorylation of NOS3 protein]
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [2,3,5-(triglutathion-S-yl)hydroquinone results in increased activity of PARP1 protein] 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Cadmium results in increased cleavage of PARP1 protein]; [1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid co-treated with Egtazic Acid] inhibits the reaction [Cadmium results in increased cleavage of PARP1 protein]
oxophenylarsine inhibits the reaction [1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid results in decreased phosphorylation of RPS6KB1 protein]
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Rotenone results in increased expression of and results in increased phosphorylation of SNCA protein]
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of and results in increased secretion of TNF protein]
chicoric acid inhibits the reaction [INS1 protein results in increased phosphorylation of AKT1 protein]; chicoric acid inhibits the reaction [INS1 protein results in increased phosphorylation of MTOR protein]
CPOX protein results in decreased carboxylation of coproporphyrinogen III Mercury inhibits the reaction [CPOX protein results in decreased carboxylation of coproporphyrinogen III]
[Egtazic Acid co-treated with Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone] inhibits the reaction [AGT protein results in increased abundance of Reactive Oxygen Species]
[Egtazic Acid co-treated with Asbestos, Crocidolite] results in increased cleavage of C5 protein; [Egtazic Acid co-treated with Asbestos, Serpentine] results in increased cleavage of C5 protein
Egtazic Acid inhibits the reaction [Paraoxon results in increased expression of and affects the activity of CASP12 protein]; Egtazic Acid inhibits the reaction [Paraoxon results in increased expression of CASP12 protein]
Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased cleavage of and results in increased activity of CASP3 protein]; Egtazic Acid promotes the reaction [Glycochenodeoxycholic Acid results in increased activity of CASP3 protein] [1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid co-treated with Egtazic Acid] inhibits the reaction [Cadmium results in increased cleavage of CASP3 protein]; Egtazic Acid inhibits the reaction [Cadmium results in increased cleavage of CASP3 protein]; Egtazic Acid inhibits the reaction [Paraoxon results in increased expression of and affects the activity of CASP3 protein]
[1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid co-treated with Egtazic Acid] inhibits the reaction [Cadmium results in increased cleavage of CASP8 protein]; Egtazic Acid inhibits the reaction [Cadmium results in increased cleavage of CASP8 protein]
Egtazic Acid inhibits the reaction [Capsaicin results in decreased phosphorylation of and results in increased activity of CFL1 protein]; Egtazic Acid inhibits the reaction [Ionomycin results in decreased phosphorylation of and results in increased activity of CFL1 protein]
[Egtazic Acid co-treated with 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester] inhibits the reaction [[CGA protein co-treated with Atrazine] results in increased expression of STAR mRNA] Egtazic Acid inhibits the reaction [cypermethrin results in increased expression of CGA mRNA]
[1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester co-treated with Egtazic Acid] inhibits the reaction [COL6A3 gene mutant form results in increased susceptibility to Rotenone]; [Cyclosporine co-treated with 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester co-treated with Egtazic Acid] inhibits the reaction [COL6A3 gene mutant form results in increased susceptibility to Rotenone]
Egtazic Acid inhibits the reaction [kaempferol results in increased secretion of CSF2 protein]; Egtazic Acid inhibits the reaction [Quercetin results in increased secretion of CSF2 protein]
Egtazic Acid inhibits the reaction [Amiodarone results in increased expression of DDIT3] [Egtazic Acid co-treated with 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid] inhibits the reaction [Cadmium results in increased expression of DDIT3 protein]; Egtazic Acid inhibits the reaction [Cadmium results in increased expression of DDIT3 protein]
Egtazic Acid inhibits the reaction [cypermethrin results in increased expression of FSHB mRNA]; Egtazic Acid inhibits the reaction [cypermethrin results in increased secretion of FSHB protein]
Egtazic Acid inhibits the reaction [2,6-di-tert-butyl-4-(3-hydroxy-2,2-dimethylpropyl)phenol promotes the reaction [gamma-Aminobutyric Acid binds to and results in increased activity of [GABBR1 protein binds to GABBR2 protein]]]
Egtazic Acid inhibits the reaction [2,6-di-tert-butyl-4-(3-hydroxy-2,2-dimethylpropyl)phenol promotes the reaction [gamma-Aminobutyric Acid binds to and results in increased activity of [GABBR1 protein binds to GABBR2 protein]]]
[1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester co-treated with Egtazic Acid] inhibits the reaction [diphenylditelluride results in increased phosphorylation of GFAP protein]
Egtazic Acid inhibits the reaction [[GNAL protein results in increased susceptibility to azelaic acid] which results in increased activity of OR55B4 protein]; Egtazic Acid inhibits the reaction [[GNAL protein results in increased susceptibility to citronellal] which results in increased activity of OR6E1 protein]; Egtazic Acid inhibits the reaction [GNAL protein results in increased susceptibility to azelaic acid]; Egtazic Acid inhibits the reaction [GNAL protein results in increased susceptibility to citronellal]; Egtazic Acid inhibits the reaction [GNAL protein results in increased susceptibility to Isoproterenol]
Egtazic Acid inhibits the reaction [[GNAS protein results in increased susceptibility to citronellal] which results in increased activity of OR6E1 protein]; Egtazic Acid inhibits the reaction [GNAS protein results in increased susceptibility to citronellal]; Egtazic Acid inhibits the reaction [GNAS protein results in increased susceptibility to Isoproterenol]
Egtazic Acid inhibits the reaction [2-tert-butylhydroquinone promotes the reaction [NFE2L2 protein binds to HMOX1 promoter]]; Egtazic Acid inhibits the reaction [2-tert-butylhydroquinone results in increased expression of HMOX1 mRNA]; Egtazic Acid inhibits the reaction [Curcumin results in increased expression of HMOX1 protein]
Egtazic Acid inhibits the reaction [Cadmium Chloride inhibits the reaction [KIF5A protein results in increased hydrolysis of Adenosine Triphosphate]]; Egtazic Acid inhibits the reaction [Cadmium Chloride results in decreased activity of KIF5A protein]; Egtazic Acid inhibits the reaction [cupric chloride results in decreased activity of KIF5A protein]
Egtazic Acid inhibits the reaction [cypermethrin results in increased expression of LHB mRNA]; Egtazic Acid inhibits the reaction [cypermethrin results in increased secretion of LHB protein]
Egtazic Acid inhibits the reaction [[Norepinephrine co-treated with Timolol] results in increased activity of and results in increased phosphorylation of MAPK1 protein]; Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Egtazic Acid inhibits the reaction [Calcimycin results in increased activity of and results in increased phosphorylation of MAPK1 protein]; Egtazic Acid inhibits the reaction [Dinoprost results in increased phosphorylation of MAPK1 protein]; Egtazic Acid inhibits the reaction [Thapsigargin results in increased activity of MAPK1 protein]; Egtazic Acid promotes the reaction [Tetracaine results in increased phosphorylation of MAPK1 protein] Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Egtazic Acid inhibits the reaction [cypermethrin results in increased phosphorylation of and results in increased activity of MAPK1 protein] Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Egtazic Acid inhibits the reaction [PDGFB protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Egtazic Acid inhibits the reaction [Vehicle Emissions results in increased localization of MAPK1 protein modified form]
Egtazic Acid inhibits the reaction [[Norepinephrine co-treated with Timolol] results in increased activity of and results in increased phosphorylation of MAPK3 protein]; Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Egtazic Acid inhibits the reaction [Calcimycin results in increased activity of and results in increased phosphorylation of MAPK3 protein]; Egtazic Acid inhibits the reaction [Dinoprost results in increased phosphorylation of MAPK3 protein]; Egtazic Acid inhibits the reaction [Thapsigargin results in increased activity of MAPK3 protein]; Egtazic Acid promotes the reaction [Tetracaine results in increased phosphorylation of MAPK3 protein] Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Egtazic Acid inhibits the reaction [cypermethrin results in increased phosphorylation of and results in increased activity of MAPK3 protein] Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Egtazic Acid inhibits the reaction [PDGFB protein results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Egtazic Acid inhibits the reaction [Vehicle Emissions results in increased localization of MAPK3 protein modified form]
Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK8 protein]; Egtazic Acid inhibits the reaction [Tetracaine results in increased phosphorylation of MAPK8 protein] Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK8 protein]; Egtazic Acid inhibits the reaction [Cadmium results in increased phosphorylation of MAPK8 protein]
Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK9 protein]; Egtazic Acid inhibits the reaction [Tetracaine results in increased phosphorylation of MAPK9 protein] Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK9 protein]; Egtazic Acid inhibits the reaction [Cadmium results in increased phosphorylation of MAPK9 protein]
Egtazic Acid inhibits the reaction [Vehicle Emissions results in increased expression of MMP1 mRNA]; Egtazic Acid inhibits the reaction [Vehicle Emissions results in increased secretion of MMP1 protein]
[1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester co-treated with Egtazic Acid] inhibits the reaction [diphenylditelluride results in increased phosphorylation of NEFL protein]
[1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester co-treated with Egtazic Acid] inhibits the reaction [diphenylditelluride results in increased phosphorylation of NEFM protein]
Egtazic Acid inhibits the reaction [2-tert-butylhydroquinone promotes the reaction [CREBBP protein binds to NFE2L2 protein]]; Egtazic Acid inhibits the reaction [2-tert-butylhydroquinone promotes the reaction [NFE2L2 protein binds to HMOX1 promoter]]; Egtazic Acid inhibits the reaction [2-tert-butylhydroquinone results in increased activity of NFE2L2 protein]
Egtazic Acid inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in increased expression of NOS1 protein alternative form] Egtazic Acid results in decreased expression of NOS1 protein alternative form
Egtazic Acid inhibits the reaction [[GNAL protein results in increased susceptibility to citronellal] which results in increased activity of OR6E1 protein]; Egtazic Acid inhibits the reaction [[GNAS protein results in increased susceptibility to citronellal] which results in increased activity of OR6E1 protein]
Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased cleavage of PARP1 protein] [1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid co-treated with Egtazic Acid] inhibits the reaction [Cadmium results in increased cleavage of PARP1 protein]; Egtazic Acid inhibits the reaction [Cadmium results in increased cleavage of PARP1 protein]
Egtazic Acid inhibits the reaction [PDGFB protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Egtazic Acid inhibits the reaction [PDGFB protein results in increased phosphorylation of and results in increased activity of MAPK3 protein]
Egtazic Acid results in decreased activity of PON1 protein [Egtazic Acid results in decreased activity of PON1 protein] which affects the susceptibility to O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate; [Egtazic Acid results in decreased activity of PON1 protein] which affects the susceptibility to oxamyl; [Egtazic Acid results in decreased activity of PON1 protein] which results in increased susceptibility to Aldicarb; [Egtazic Acid results in decreased activity of PON1 protein] which results in increased susceptibility to methylparaoxon; [Egtazic Acid results in decreased activity of PON1 protein] which results in increased susceptibility to Paraoxon [Egtazic Acid results in decreased activity of PON1 protein] which results in increased susceptibility to Aldicarb; [Egtazic Acid results in decreased activity of PON1 protein] which results in increased susceptibility to methylparaoxon; [Egtazic Acid results in decreased activity of PON1 protein] which results in increased susceptibility to O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate; [Egtazic Acid results in decreased activity of PON1 protein] which results in increased susceptibility to oxamyl; [Egtazic Acid results in decreased activity of PON1 protein] which results in increased susceptibility to Paraoxon
Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased phosphorylation of RPS6KB1 protein] Egtazic Acid inhibits the reaction [arsenite results in increased phosphorylation of and results in increased activity of RPS6KB1 protein]; Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased phosphorylation of RPS6KB1 protein]
Egtazic Acid inhibits the reaction [cypermethrin results in increased expression of STAR mRNA]; Egtazic Acid inhibits the reaction [Quercetin results in increased expression of STAR mRNA] [Egtazic Acid co-treated with 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester] inhibits the reaction [[CGA protein co-treated with Atrazine] results in increased expression of STAR mRNA]
Egtazic Acid inhibits the reaction [TNF protein results in increased transport of Chlorides]; Egtazic Acid inhibits the reaction [TNF protein results in increased transport of Potassium]
Egtazic Acid inhibits the reaction [anandamide binds to and results in increased activity of TRPV1 protein]; Egtazic Acid inhibits the reaction [Capsaicin binds to and results in increased activity of TRPV1 protein]; Egtazic Acid inhibits the reaction [N-(4-hydroxyphenyl)arachidonylamide binds to and results in increased activity of TRPV1 protein]
[1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester co-treated with Egtazic Acid] inhibits the reaction [diphenylditelluride results in increased phosphorylation of VIM protein]
Edetic Acid inhibits the reaction [[[[APP protein modified form binds to Copper] which co-treated with Ascorbic Acid] results in increased oxidation of phosphatidylcholine hydroperoxide] which results in increased chemical synthesis of 4-hydroxy-2-nonenal]; Edetic Acid inhibits the reaction [[[[APP protein modified form binds to Copper] which co-treated with Ascorbic Acid] results in increased oxidation of Phosphatidylcholines] which results in increased chemical synthesis of phosphatidylcholine hydroperoxide]
[ferrous sulfate co-treated with Edetic Acid] results in decreased activity of ATP2A1 protein; Butylated Hydroxytoluene inhibits the reaction [[ferrous sulfate co-treated with Edetic Acid] results in decreased activity of ATP2A1 protein]; dicarbine inhibits the reaction [[ferrous sulfate co-treated with Edetic Acid] results in decreased activity of ATP2A1 protein]
[Edetic Acid inhibits the reaction [Calcium binds to MGP protein]] inhibits the reaction [MGP protein binds to BMP4 protein]; Edetic Acid inhibits the reaction [Calcium binds to MGP protein]
Edetic Acid inhibits the reaction [2-tert-butylhydroquinone results in increased expression of MT1 mRNA]; Edetic Acid inhibits the reaction [zinc chloride promotes the reaction [2-tert-butylhydroquinone results in increased expression of MT1 mRNA]]
[tris(2-carboxyethyl)phosphine co-treated with Edetic Acid] inhibits the reaction [Copper results in decreased activity of NEIL1 protein]; Edetic Acid inhibits the reaction [Iron binds to and results in decreased activity of NEIL1 protein]
Edetic Acid inhibits the reaction [Oxygen deficiency results in increased degradation of OPTC protein]; Edetic Acid inhibits the reaction [VEGFA protein results in increased degradation of OPTC protein]
Edetic Acid inhibits the reaction [Zinc results in increased expression of PLAT mRNA]; Edetic Acid inhibits the reaction [Zinc results in increased expression of PLAT protein]; Edetic Acid inhibits the reaction [Zinc results in increased secretion of PLAT protein]
Edetic Acid inhibits the reaction [Zinc results in increased expression of PLG mRNA]; Edetic Acid inhibits the reaction [Zinc results in increased expression of PLG protein]
Edetic Acid inhibits the reaction [[Hydrogen Peroxide co-treated with Copper] results in increased cleavage of PRNP protein]; Edetic Acid inhibits the reaction [[Hydrogen Peroxide co-treated with Iron] results in increased cleavage of PRNP protein]
Edetic Acid inhibits the reaction [Copper promotes the reaction [S100A2 protein binds to S100A2 protein]]; Edetic Acid inhibits the reaction [S100A2 protein binds to S100A2 protein]
Edetic Acid results in increased expression of SLC30A10 mRNA; Edetic Acid results in increased expression of SLC30A10 protein Edetic Acid inhibits the reaction [SLC30A10 gene mutant form results in increased abundance of Manganese]
Adenosine Triphosphate inhibits the reaction [Edetic Acid inhibits the reaction [SRR protein results in increased abundance of D-Aspartic Acid]]; Edetic Acid inhibits the reaction [SRR protein results in increased abundance of D-Aspartic Acid]
Edetic Acid inhibits the reaction [[Cadmium Chloride results in decreased activity of TP53 protein] inhibits the reaction [TP53 protein binds to TP53 gene]]; Edetic Acid inhibits the reaction [[Cadmium Chloride results in decreased activity of TP63 protein] inhibits the reaction [TP63 protein binds to TP53 gene]]; Edetic Acid inhibits the reaction [[Cadmium Chloride results in decreased activity of TP73 protein] inhibits the reaction [TP73 protein binds to TP53 gene]]
Edetic Acid inhibits the reaction [[Cadmium Chloride results in decreased activity of TP63 protein] inhibits the reaction [TP63 protein binds to TP53 gene]]
Edetic Acid inhibits the reaction [[Cadmium Chloride results in decreased activity of TP73 protein] inhibits the reaction [TP73 protein binds to TP53 gene]]
[XDH protein co-treated with Edetic Acid analog] results in increased oxidation of Uroporphyrinogens; CAT inhibits the reaction [[XDH protein co-treated with Edetic Acid analog] results in increased oxidation of Uroporphyrinogens]
fumonisin B1 inhibits the reaction [nickel chloride results in increased expression of ABCB1 protein] fumonisin B1 inhibits the reaction [ABCB1 protein results in decreased susceptibility to Doxorubicin]
[NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of ABCG8 mRNA; [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of ABCG8 mRNA
fumonisin B1 inhibits the reaction [AGT protein results in increased expression of MDM2 mRNA]; fumonisin B1 inhibits the reaction [AGT protein results in increased expression of MDM2 protein] fumonisin B1 results in decreased expression of AGT mRNA
[fumonisin B1 co-treated with ochratoxin A] results in increased expression of APAF1 protein; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of APAF1 mRNA]
fumonisin B1 results in increased expression of ATF4 mRNA; fumonisin B1 results in increased expression of ATF4 protein EIF2AK3 protein affects the reaction [fumonisin B1 results in increased expression of ATF4 protein]
[fumonisin B1 results in decreased chemical synthesis of Ceramides] which results in decreased expression of BAX protein [fumonisin B1 co-treated with ochratoxin A] results in increased expression of BAX protein; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of BAX mRNA] fumonisin B1 affects the expression of BAX mRNA fumonisin B1 results in increased expression of BAX protein fumonisin B1 results in increased expression of BAX mRNA; fumonisin B1 results in increased expression of BAX protein
fumonisin B1 results in decreased expression of BCL2 mRNA; fumonisin B1 results in decreased expression of BCL2 protein fumonisin B1 promotes the reaction [ochratoxin A results in decreased expression of BCL2 mRNA]; fumonisin B1 promotes the reaction [ochratoxin A results in decreased expression of BCL2 protein]
fumonisin B1 results in increased cleavage of CASP1 protein deoxynivalenol promotes the reaction [fumonisin B1 results in increased cleavage of CASP1 protein]; fumonisin B1 promotes the reaction [deoxynivalenol results in increased cleavage of CASP1 protein] fumonisin B1 results in increased expression of CASP1 mRNA
fumonisin B1 results in increased expression of CASP3 mRNA [fumonisin B1 co-treated with ochratoxin A] results in increased cleavage of CASP3 protein; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of CASP3 mRNA] fumonisin B1 results in decreased expression of CASP3 mRNA fumonisin B1 results in decreased expression of and results in increased cleavage of CASP3 protein
[fumonisin B1 co-treated with ochratoxin A] results in increased cleavage of CASP9 protein; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of CASP9 mRNA]
fumonisin B1 results in increased activity of CAT protein [fumonisin B1 co-treated with ochratoxin A] results in increased activity of CAT protein fumonisin B1 results in decreased expression of CAT mRNA [Aflatoxin B1 co-treated with fumonisin B1] results in increased activity of CAT protein
fumonisin B1 results in increased expression of CD63 mRNA [NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of CD63 mRNA; [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of CD63 mRNA
fumonisin B1 results in increased expression of CDKN1A mRNA [fumonisin B1 results in decreased chemical synthesis of Ceramides] which results in decreased expression of CDKN1A protein
[fumonisin B1 co-treated with Particulate Matter] results in increased expression of CERS2 mRNA; [fumonisin B1 co-treated with Vehicle Emissions] results in increased expression of CERS2 mRNA
[NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of COL1A1 mRNA; [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of COL1A1 mRNA
[NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of COL3A1 mRNA; [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of COL3A1 mRNA
[NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of CXCL14 mRNA; [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of CXCL14 mRNA
fumonisin B1 results in increased expression of CYCS mRNA; fumonisin B1 results in increased expression of CYCS protein fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of CYCS mRNA]
[NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of CYP7B1 mRNA; [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of CYP7B1 mRNA
fumonisin B1 results in increased expression of DDIT3 mRNA; fumonisin B1 results in increased expression of DDIT3 protein 4-phenylbutyric acid inhibits the reaction [fumonisin B1 results in increased expression of DDIT3 protein]; EIF2AK3 protein affects the reaction [fumonisin B1 results in increased expression of DDIT3 protein]; thermozymocidin inhibits the reaction [fumonisin B1 results in increased expression of DDIT3 protein]
fumonisin B1 results in increased expression of EIF2AK3 protein EIF2AK3 protein affects the reaction [fumonisin B1 results in increased expression of ATF4 protein]; EIF2AK3 protein affects the reaction [fumonisin B1 results in increased expression of DDIT3 protein]
[NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of ELOVL7 mRNA; [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of ELOVL7 mRNA
fumonisin B1 inhibits the reaction [[sorafenib co-treated with vorinostat] affects the localization of and results in increased activity of FAS protein]
fumonisin B1 results in increased activity of GPT protein [NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of GPT protein; [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of GPT protein
deoxynivalenol promotes the reaction [fumonisin B1 results in increased expression of GSDMD mRNA]; deoxynivalenol promotes the reaction [fumonisin B1 results in increased expression of GSDMD protein]; fumonisin B1 promotes the reaction [deoxynivalenol results in increased expression of GSDMD mRNA]; fumonisin B1 promotes the reaction [deoxynivalenol results in increased expression of GSDMD protein] fumonisin B1 results in increased expression of GSDMD mRNA; fumonisin B1 results in increased expression of GSDMD protein
fumonisin B1 results in increased expression of HSPA5 mRNA; fumonisin B1 results in increased expression of HSPA5 protein 4-phenylbutyric acid inhibits the reaction [fumonisin B1 results in increased expression of HSPA5 protein]; thermozymocidin inhibits the reaction [fumonisin B1 results in increased expression of HSPA5 protein]
fumonisin B1 results in increased expression of IFNG mRNA fumonisin B1 affects the expression of IFNG mRNA 5'-methylthioadenosine inhibits the reaction [fumonisin B1 results in increased expression of IFNG mRNA]; S-Adenosylmethionine inhibits the reaction [fumonisin B1 results in increased expression of IFNG mRNA]
fumonisin B1 results in increased secretion of IL18 protein deoxynivalenol promotes the reaction [fumonisin B1 results in increased expression of IL18 mRNA]; deoxynivalenol promotes the reaction [fumonisin B1 results in increased expression of IL18 protein]; deoxynivalenol promotes the reaction [fumonisin B1 results in increased secretion of IL18 protein]; fumonisin B1 promotes the reaction [deoxynivalenol results in increased expression of IL18 mRNA]; fumonisin B1 promotes the reaction [deoxynivalenol results in increased expression of IL18 protein]; fumonisin B1 promotes the reaction [deoxynivalenol results in increased secretion of IL18 protein] fumonisin B1 results in increased expression of IL18 mRNA; fumonisin B1 results in increased expression of IL18 protein
5'-methylthioadenosine inhibits the reaction [fumonisin B1 results in increased expression of IL1B mRNA]; deoxynivalenol promotes the reaction [fumonisin B1 results in increased expression of IL1B mRNA]; deoxynivalenol promotes the reaction [fumonisin B1 results in increased expression of IL1B protein]; deoxynivalenol promotes the reaction [fumonisin B1 results in increased secretion of IL1B protein]; fumonisin B1 promotes the reaction [deoxynivalenol results in increased expression of IL1B mRNA]; fumonisin B1 promotes the reaction [deoxynivalenol results in increased expression of IL1B protein]; fumonisin B1 promotes the reaction [deoxynivalenol results in increased secretion of IL1B protein]; necrostatin-1 inhibits the reaction [fumonisin B1 results in increased expression of IL1B mRNA]; S-Adenosylmethionine inhibits the reaction [fumonisin B1 results in increased expression of IL1B mRNA] fumonisin B1 results in decreased expression of IL1B mRNA fumonisin B1 results in increased expression of IL1B mRNA; fumonisin B1 results in increased expression of IL1B protein
5'-methylthioadenosine inhibits the reaction [fumonisin B1 results in increased expression of IL2 mRNA]; S-Adenosylmethionine inhibits the reaction [fumonisin B1 results in increased expression of IL2 mRNA] fumonisin B1 affects the expression of IL2 mRNA
fumonisin B1 results in increased expression of IL6 mRNA 5'-methylthioadenosine inhibits the reaction [fumonisin B1 results in increased expression of IL6 mRNA]; deoxynivalenol promotes the reaction [fumonisin B1 results in increased expression of IL6 mRNA]; fumonisin B1 promotes the reaction [deoxynivalenol results in increased expression of IL6 mRNA]; necrostatin-1 inhibits the reaction [fumonisin B1 results in increased expression of IL6 mRNA]; S-Adenosylmethionine inhibits the reaction [fumonisin B1 results in increased expression of IL6 mRNA]
fumonisin B1 inhibits the reaction [(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone results in decreased phosphorylation of and results in decreased activity of KDR protein]; fumonisin B1 inhibits the reaction [1,1-dimethylbutyl-1-deoxy-Delta(9)-THC results in decreased phosphorylation of and results in decreased activity of KDR protein]
fumonisin B1 results in increased methylation of KEAP1 promoter fumonisin B1 results in decreased expression of KEAP1 mRNA fumonisin B1 results in decreased expression of KEAP1 mRNA; fumonisin B1 results in decreased expression of KEAP1 protein [fumonisin B1 results in increased methylation of KEAP1 promoter] which results in decreased expression of KEAP1 mRNA
fumonisin B1 results in increased expression of LTB mRNA 5'-methylthioadenosine inhibits the reaction [fumonisin B1 results in increased expression of LTB mRNA]; S-Adenosylmethionine inhibits the reaction [fumonisin B1 results in increased expression of LTB mRNA]
fumonisin B1 inhibits the reaction [AGT protein results in increased expression of MDM2 mRNA]; fumonisin B1 inhibits the reaction [AGT protein results in increased expression of MDM2 protein]
fumonisin B1 results in decreased expression of MIR27B mRNA [fumonisin B1 results in decreased expression of MIR27B mRNA] which results in increased expression of NFE2L2 mRNA; [fumonisin B1 results in decreased expression of MIR27B mRNA] which results in increased expression of NFE2L2 protein; MIR27B mRNA inhibits the reaction [fumonisin B1 results in increased expression of NFE2L2 mRNA]; MIR27B mRNA inhibits the reaction [fumonisin B1 results in increased expression of NFE2L2 protein]
fumonisin B1 results in increased expression of MLKL mRNA; fumonisin B1 results in increased expression of MLKL protein 3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [fumonisin B1 results in increased expression of MLKL mRNA]; 3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [fumonisin B1 results in increased expression of MLKL protein]; necrostatin-1 inhibits the reaction [fumonisin B1 results in increased expression of MLKL mRNA]; necrostatin-1 inhibits the reaction [fumonisin B1 results in increased expression of MLKL protein]
fumonisin B1 results in increased expression of and results in increased secretion of MUC5AC protein fumonisin B1 results in increased expression of MUC5AC mRNA
fumonisin B1 results in increased expression of and results in increased secretion of MUC5B protein fumonisin B1 results in increased expression of MUC5B mRNA
fumonisin B1 results in increased expression of NFE2L2 mRNA fumonisin B1 affects the expression of NFE2L2 mRNA fumonisin B1 results in increased methylation of NFE2L2 mRNA fumonisin B1 results in decreased methylation of NFE2L2 promoter [fumonisin B1 results in decreased expression of MIR27B mRNA] which results in increased expression of NFE2L2 mRNA; [fumonisin B1 results in decreased expression of MIR27B mRNA] which results in increased expression of NFE2L2 protein; [fumonisin B1 results in decreased methylation of NFE2L2 promoter] which results in increased expression of NFE2L2 mRNA; MIR27B mRNA inhibits the reaction [fumonisin B1 results in increased expression of NFE2L2 mRNA]; MIR27B mRNA inhibits the reaction [fumonisin B1 results in increased expression of NFE2L2 protein] fumonisin B1 results in increased expression of NFE2L2 mRNA; fumonisin B1 results in increased expression of NFE2L2 protein
fumonisin B1 results in increased expression of NLRP3 mRNA; fumonisin B1 results in increased expression of NLRP3 protein deoxynivalenol promotes the reaction [fumonisin B1 results in increased expression of NLRP3 mRNA]; deoxynivalenol promotes the reaction [fumonisin B1 results in increased expression of NLRP3 protein]; fumonisin B1 promotes the reaction [deoxynivalenol results in increased expression of NLRP3 mRNA]; fumonisin B1 promotes the reaction [deoxynivalenol results in increased expression of NLRP3 protein]
NR1H2 protein affects the susceptibility to fumonisin B1 [NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of ABCG8 mRNA; [NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of CD63 mRNA; [NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of COL1A1 mRNA; [NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of COL3A1 mRNA; [NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of CXCL14 mRNA; [NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of CYP7B1 mRNA; [NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of ELOVL7 mRNA; [NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of GPT protein; [NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of RAB7B mRNA; [NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of SMPD3 mRNA; [NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of TM7SF2 mRNA; [NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of UGT2B1 mRNA
[NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of ABCG8 mRNA; [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of CD63 mRNA; [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of COL1A1 mRNA; [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of COL3A1 mRNA; [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of CXCL14 mRNA; [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of CYP7B1 mRNA; [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of ELOVL7 mRNA; [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of GPT protein; [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of RAB7B mRNA; [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of SMPD3 mRNA; [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of TM7SF2 mRNA; [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of UGT2B1 mRNA
fumonisin B1 results in increased expression of NTN1 mRNA necrostatin-1 inhibits the reaction [fumonisin B1 results in increased expression of NTN1 mRNA]
fumonisin B1 inhibits the reaction [nickel chloride results in increased cleavage of PARP1 protein] fumonisin B1 results in decreased cleavage of PARP1 protein
[deoxynivalenol co-treated with fumonisin B1] results in increased expression of PYCARD mRNA; [deoxynivalenol co-treated with fumonisin B1] results in increased expression of PYCARD protein
[NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of RAB7B mRNA; [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of RAB7B mRNA
fumonisin B1 results in increased expression of RIPK1 mRNA; fumonisin B1 results in increased expression of RIPK1 protein 3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [fumonisin B1 results in increased expression of RIPK1 mRNA]; 3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [fumonisin B1 results in increased expression of RIPK1 protein]; necrostatin-1 inhibits the reaction [fumonisin B1 results in increased expression of RIPK1 mRNA]; necrostatin-1 inhibits the reaction [fumonisin B1 results in increased expression of RIPK1 protein]
3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [fumonisin B1 results in increased expression of RIPK3 mRNA]; 3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [fumonisin B1 results in increased expression of RIPK3 protein]; necrostatin-1 inhibits the reaction [fumonisin B1 results in increased expression of RIPK3 mRNA]; necrostatin-1 inhibits the reaction [fumonisin B1 results in increased expression of RIPK3 protein] fumonisin B1 results in increased expression of RIPK3 mRNA; fumonisin B1 results in increased expression of RIPK3 protein
[NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of SMPD3 mRNA; [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of SMPD3 mRNA
fumonisin B1 inhibits the reaction [Particulate Matter results in increased expression of SPHK1 mRNA]; fumonisin B1 inhibits the reaction [Vehicle Emissions results in increased expression of SPHK1 mRNA]
[NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of TM7SF2 mRNA; [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of TM7SF2 mRNA
fumonisin B1 results in increased expression of TNF mRNA; fumonisin B1 results in increased expression of TNF protein 3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [fumonisin B1 results in increased expression of TNF mRNA]; 3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [fumonisin B1 results in increased expression of TNF protein]; necrostatin-1 inhibits the reaction [fumonisin B1 results in increased expression of TNF mRNA]; necrostatin-1 inhibits the reaction [fumonisin B1 results in increased expression of TNF protein] fumonisin B1 results in decreased expression of TNF mRNA; fumonisin B1 results in decreased expression of TNF protein
[fumonisin B1 results in decreased chemical synthesis of Ceramides] which affects the splicing of and results in decreased expression of TP53 mRNA; [fumonisin B1 results in decreased chemical synthesis of Ceramides] which results in decreased phosphorylation of TP53 protein modified form Acetylcysteine inhibits the reaction [Aflatoxin B1 promotes the reaction [fumonisin B1 results in increased expression of TP53 protein]]; Acetylcysteine inhibits the reaction [fumonisin B1 promotes the reaction [Aflatoxin B1 results in increased expression of TP53 protein]]; Aflatoxin B1 promotes the reaction [fumonisin B1 results in increased expression of TP53 protein]; fumonisin B1 promotes the reaction [Aflatoxin B1 results in increased expression of TP53 protein] fumonisin B1 results in decreased expression of TP53 mRNA
[NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of UGT2B1 mRNA; [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of UGT2B1 mRNA
fumonisin B1 inhibits the reaction [(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone results in decreased expression of and results in decreased secretion of VEGFA protein]; fumonisin B1 inhibits the reaction [1,1-dimethylbutyl-1-deoxy-Delta(9)-THC results in decreased expression of and results in decreased secretion of VEGFA protein]
Verteporfin inhibits the reaction [AMOTL1 protein results in increased activity of YAP1 protein] Verteporfin results in decreased susceptibility to AMOTL1 protein
verteporfin inhibits the reaction [YAP1 protein results in increased expression of ANKRD1 mRNA] Verteporfin inhibits the reaction [1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of ANKRD1 mRNA] verteporfin results in decreased expression of ANKRD1 mRNA
Verteporfin inhibits the reaction [Melatonin inhibits the reaction [Doxorubicin results in decreased expression of and results in increased cleavage of CASP9 protein]]
Verteporfin inhibits the reaction [YAP1 protein results in increased expression of CCN1 mRNA] Verteporfin inhibits the reaction [1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of CCN1 mRNA] Verteporfin results in decreased expression of CCN1 mRNA
Verteporfin results in decreased expression of CCN2 mRNA Verteporfin inhibits the reaction [[XMU-MP-1 co-treated with Cadmium Chloride] results in increased expression of CCN2 mRNA] Verteporfin inhibits the reaction [YAP1 protein results in increased expression of CCN2 mRNA]
[Verteporfin co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in decreased expression of JAK1 protein Verteporfin results in decreased expression of JAK1 protein
Verteporfin results in decreased expression of JAK2 protein [Verteporfin co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in decreased expression of JAK2 protein
[Verteporfin co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in decreased expression of RELA protein; Verteporfin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the localization of and results in increased phosphorylation of RELA protein]
Verteporfin results in decreased expression of STAT1 protein Verteporfin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of and results in increased phosphorylation of STAT1 protein]
Verteporfin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of and results in increased phosphorylation of STAT3 protein] Verteporfin results in decreased expression of STAT3 protein
Verteporfin inhibits the reaction [AMOTL1 protein results in increased activity of YAP1 protein]; Verteporfin inhibits the reaction [RASAL2 protein results in increased activity of YAP1 protein]; Verteporfin inhibits the reaction [YAP1 protein results in increased expression of ANKRD1 mRNA]; Verteporfin inhibits the reaction [YAP1 protein results in increased expression of CCN1 mRNA]; Verteporfin inhibits the reaction [YAP1 protein results in increased expression of CCN2 mRNA] Verteporfin inhibits the reaction [Melatonin inhibits the reaction [Doxorubicin results in increased phosphorylation of YAP1 protein]] Verteporfin results in decreased expression of YAP1 protein Verteporfin results in decreased activity of YAP1 protein Verteporfin inhibits the reaction [YAP1 protein binds to TEAD1 protein]
browse the term
